Ectopic expression of MYCN, as well as primary tumors with MYCN amplification, express an up‐regulation of a specific miR signature that correlates with a poor prognosis and may positively contribute to NB pathogenesis (Mestdagh et al., 2010; Schulte et al., 2008). This evidence concerns the gene MYCN and neuroblastoma.